U.S. appeals court ruling may clear barrier to generic OxyContin

(Reuters) - A federal appeals court ruled Monday that four patents related to Purdue Pharma's painkiller OxyContin are invalid, potentially bringing Teva Pharmaceutical Industries Ltd and others a step closer to introducing generic versions of the drug.

http://ift.tt/1UDZ6Uu

from Reuters: Health News
via animenewspro